|
DNA Ginkgo Bioworks Holdings Inc 1830214 |
| Balance Sheet |
|
Current Assets
|
$409,955,000.00 |
|
Assets
|
$1,033,075,000.00 |
|
Current Liabilities
|
$79,595,000.00 |
|
Liabilities
|
$589,922,000.00 |
|
Equity
|
$443,153,000.00 |
|
Shares Out
|
61660788.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-46,686,000.00 |
|
Investing Cash Flow
|
$23,132,000.00 |
| Market Analysis |
Market Cap
|
$498,835,774.92 |
|
Price
|
$8.29 |
|
BVPS
|
7.19 |
|
PB
|
1.13 |
|
EPS
|
-1.39 |
|
PS
|
8.23 |
|
FCF
|
$-48,619,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:25 |
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-5.64 |
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-1.39 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.10 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.45 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DNA documents filed with the SEC.
DNA Filings
Clear